La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Bright Mountain Media a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Bright Mountain Media..

Bright Mountain Media (OTC:BMTM) Azioni, Catena delle Opzioni

Bright Mountain Media Inc is a holding company that focuses on digital publishing and advertising technology. The Company is engaged in content creation and advertising technology development that helps customers connect with, and market to, targeted audiences in high-quality environments using a variety of digital ad formats. It generates revenue through sales of advertising services which generate revenue from advertisements placed on the Company's owned and managed sites, as well as from advertisements placed on partner websites, for which the company earns a share of the revenue.

BRIGHT MOUNTAIN MEDIA INC by Bright Mountain Media, Inc.

Bright Mountain Media Inc

Cross Country Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCRN#NASDAQ">CCRN</a>) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 by 20 percent. The company reported quarterly sales of $315.119 million which beat the analyst consensus estimate of $310.218 million by 1.58 percent. This is a 28.75 percent decrease over sales of $442.291 million the same period last year.

Earnings

Earnings Beats

News

CCRN

Cross Country Healthcare Q3 2024 Adj. EPS $0.12 Beats $0.10 Estimate, Revenue From Services $315.119M Beat $310.218M Estimate

GFL Environmental Q3 2024 Adj. EPS C$0.23 Misses C$0.35 Estimate, Sales C$2.015B Miss C$2.052B Estimate

Zillow Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.29 by 20.69 percent. The company reported quarterly sales of $581.00 million which beat the analyst consensus estimate of $554.68 million by 4.75 percent. This is a 17.14 percent increase over sales of $496.00 million the same period last year.

Zillow Gr Q3 2024 Adj EPS $0.35 Beats $0.29 Estimate, Sales $581.00M Beat $554.68M Estimate

Williams Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.42 by 2.38 percent. The company reported quarterly sales of $2.653 billion which beat the analyst consensus estimate of $2.485 billion by 6.76 percent. This is a 3.67 percent increase over sales of $2.559 billion the same period last year.

Williams Companies Q3 2024 Adj. EPS $0.43 Beats $0.42 Estimate, Sales $2.653B Beat $2.485B Estimate

CS Disco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAW#NYSE">LAW</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $36.27 million which missed the analyst consensus estimate of $36.33 million by 0.18 percent. This is a 3.79 percent increase over sales of $34.94 million the same period last year.

Earnings Misses

CS Disco Q3 Adj $(0.06) Beats $(0.09) Estimate, Sales $36.27M Miss $36.33M Estimate

Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) raises FY2024 sales outlook from $1.05 billion-1.13 billion to $1.06 billion-1.13 billion.

Guidance

Emergent BioSolutions Raises FY2024 Sales Guidance from $1.05B-1.13B to $1.06B-1.13B

Marriott Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAC#NYSE">VAC</a>) reported quarterly earnings of $1.80 per share which beat the analyst consensus estimate of $1.57 by 14.65 percent. The company reported quarterly sales of $1.305 billion which beat the analyst consensus estimate of $1.267 billion by 3.01 percent. This is a 10.03 percent increase over sales of $1.186 billion the same period last year.

Marriott Vacations Q3 2024 Adj. EPS $1.80 Beats $1.57 Estimate, Sales $1.305B Beat $1.267B Estimate

TKO Group Holdings Sees FY24 Revenue To Upper End Of $2.67B-$2.745B Vs $2.758B Est.

Buybacks

AMPH

Amphastar Pharmaceuticals Expands Share Buyback Program By $50M To Offset Equity Compensation Dilution, With No Set End Date

SLR Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRC#NASDAQ">SLRC</a>) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.42 by 7.14 percent. The company reported quarterly sales of $59.771 million which beat the analyst consensus estimate of $57.979 million by 3.09 percent. This is a 0.22 percent increase over sales of $59.641 million the same period last year.

SLRC

SLR Inv Q3 2024 GAAP EPS $0.45 Beats $0.42 Estimate, Sales $59.771M Beat $57.979M Estimate

A-Mark Precious Metals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRK#NASDAQ">AMRK</a>) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0.87 by 57.47 percent. The company reported quarterly sales of $2.715 billion which beat the analyst consensus estimate of $2.622 billion by 3.53 percent. This is a 9.26 percent increase over sales of $2.485 billion the same period last year.

AMRK

A-Mark Precious Metals Q1 2025 Adj. EPS $0.37 Misses $0.87 Estimate, Sales $2.715B Beat $2.622B Estimate

Faro Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) is looking for Q4 Adj EPS of $0.32-0.52 vs $0.31 analyst estimate. seessales of $88.000 million-96.000 million vs $91.55 million estimate.

FARO

Faro Technologies Sees Q4 Adj EPS $0.32-0.52 vs $0.31 Est; Sees Sales $88.000M-96.000M vs $91.55M Est

Faro Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) is looking for Q4 GAAP EPS of $(0.15)-0.05 vs $0.01 analyst estimate..

Faro Technologies Sees Q4 GAAP EPS $(0.15)-0.05 vs $0.01 Est

Amphastar Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPH#NASDAQ">AMPH</a>) reported quarterly earnings of $0.96 per share which missed the analyst consensus estimate of $0.99 by 3.03 percent. The company reported quarterly sales of $191.20 million which missed the analyst consensus estimate of $194.69 million by 1.79 percent. This is a 5.90 percent increase over sales of $180.56 million the same period last year.

Amphastar Pharma Q3 2024 Adj EPS $0.96 Misses $0.99 Estimate, Sales $191.20M Miss $194.69M Estimate

ZipRecruiter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIP#NYSE">ZIP</a>) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.09) by 66.67 percent. The company reported quarterly sales of $117.084 million which beat the analyst consensus estimate of $112.612 million by 3.97 percent. This is a 24.77 percent decrease over sales of $155.630 million the same period last year.

ZipRecruiter Q3 2024 GAAP EPS $(0.03) Beats $(0.09) Estimate, Sales $117.084M Beat $112.612M Estimate

The Company has identified and intends to realize annualized G&amp;A and operating expense savings of between $15 million and $20 million on a run-rate basis from the restructuring.
&nbsp;

Management

Sun Communities Plans Restructuring, John McLaren Returning As President; CEO Gary Shiffman Informs His Intention To Retire In 2025

Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.08 by 37.5 percent. The company reported quarterly sales of $186.600 million which beat the analyst consensus estimate of $181.637 million by 2.73 percent. This is a 21.52 percent increase over sales of $153.550 million the same period last year.

FRSH

Freshworks Q3 2024 Adj. EPS $0.11 Beats $0.08 Estimate, Sales $186.600M Beat $181.637M Estimate

EHAB

Enhabit Sees FY24 Adj. EPS $0.19-$0.29 Vs $0.27 Est.; Revenue $1.031B-$1.046B Vs 1.054B Est.

Stock Split

Signing Day Sports Announced A 1-48 Reverse Stock Spilt Effective On November 16, 2024

Innovate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) reported quarterly losses of $(1.18) per share. This is a 31.11 percent decrease over losses of $(0.90) per share from the same period last year. The company reported $242.20 million in sales this quarter. This is a 35.46 percent decrease over sales of $375.30 million the same period last year.

Comments

Bright Mountain Media

Bright Mountain Media (BMTM) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO